262 related articles for article (PubMed ID: 25028781)
1. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
Mazurowski MA; Zhang J; Grimm LJ; Yoon SC; Silber JI
Radiology; 2014 Nov; 273(2):365-72. PubMed ID: 25028781
[TBL] [Abstract][Full Text] [Related]
2. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Grimm LJ; Zhang J; Mazurowski MA
J Magn Reson Imaging; 2015 Oct; 42(4):902-7. PubMed ID: 25777181
[TBL] [Abstract][Full Text] [Related]
3. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
Grimm LJ; Johnson KS; Marcom PK; Baker JA; Soo MS
Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
[TBL] [Abstract][Full Text] [Related]
5. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
6. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.
van der Velden BH; Dmitriev I; Loo CE; Pijnappel RM; Gilhuijs KG
Radiology; 2015 Sep; 276(3):675-85. PubMed ID: 25811614
[TBL] [Abstract][Full Text] [Related]
7. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
[TBL] [Abstract][Full Text] [Related]
9. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
10. Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
Millet I; Curros-Doyon F; Molinari N; Bouic-Pages E; Prat X; Alili C; Taourel P
Radiology; 2014 Jan; 270(1):57-66. PubMed ID: 24029641
[TBL] [Abstract][Full Text] [Related]
11. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
13. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Uematsu T; Kasami M; Yuen S
Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
[TBL] [Abstract][Full Text] [Related]
16. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Sutton EJ; Oh JH; Dashevsky BZ; Veeraraghavan H; Apte AP; Thakur SB; Deasy JO; Morris EA
J Magn Reson Imaging; 2015 Nov; 42(5):1398-406. PubMed ID: 25850931
[TBL] [Abstract][Full Text] [Related]
18. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
[TBL] [Abstract][Full Text] [Related]
19. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status.
Hegenscheid K; Schmidt CO; Seipel R; Laqua R; Ohlinger R; Kühn JP; Hosten N; Puls R
Radiology; 2013 Jan; 266(1):72-80. PubMed ID: 23023963
[TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study.
Schrading S; Schild H; Kühr M; Kuhl C
Radiology; 2014 Apr; 271(1):45-55. PubMed ID: 24475835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
